-
公开(公告)号:US20210061919A1
公开(公告)日:2021-03-04
申请号:US16947021
申请日:2020-07-15
Applicant: GENMAB A/S
Inventor: Jan VAN DE WINKEL , Tom VINK , Janine SCHUURMAN , Paul PARREN , Rob AALBERSE , Marijn VAN DER NEUT KOLFSCHOTEN
Abstract: The present invention relates to novel stabilized IgG4 antibodies, to methods of producing such antibodies and to uses of such antibodies as a medicament. In a main aspect, the invention relates to a stabilized IgG4 antibody, comprising a heavy chain and a light chain, wherein said heavy chain comprises a human IgG4 constant region having a substitution of the Arg residue at position (409), the Phe residue at position (405) or the Lys residue at position (370).
-
公开(公告)号:US10927181B2
公开(公告)日:2021-02-23
申请号:US16582534
申请日:2019-09-25
Applicant: BIONTECH SE , GENMAB A/S
Inventor: Ugur Sahin , Friederike Gieseke , Isil Altintas , David Satijn , Paul Parren
IPC: C07K16/28
Abstract: The present invention relates to binding agents binding to receptors of the TNF superfamily, in particular binding agents binding to at least two different receptors of the TNF superfamily, as well as to their use in medicine. The present invention further relates to nucleic acid molecules encoding such binding agents, to cells comprising such nucleic acid molecules and to pharmaceutical compositions and kits.
-
公开(公告)号:US20200317799A1
公开(公告)日:2020-10-08
申请号:US16689361
申请日:2019-11-20
Applicant: Genmab A/S
Inventor: Jessica Teeling , Sigrid Ruuls , Martin Glennie , Jan G.J. van de Winkel , Paul Parren , Jørgen Petersen , Ole Baadsgaard , Haichun Huang
IPC: C07K16/28 , C07K16/42 , A61K39/395 , A61K45/06 , G01N33/68
Abstract: Isolated human monoclonal antibodies which bind to and inhibit human CD20, and related antibody-based compositions and molecules, are disclosed. The human antibodies can be produced by a transfectoma or in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
-
公开(公告)号:US10512688B2
公开(公告)日:2019-12-24
申请号:US15325364
申请日:2015-07-10
Applicant: GENMAB A/S
Inventor: Esther Breij , David Satijn , Edward Norbert Van Den Brink , Dennis Verzijl , Rob N. De Jong , Paul Parren , Riemke Van Dijkhuizen Radersma
IPC: A61K39/395 , C07K16/28 , A61K47/68 , A61K39/00 , C07K16/30
Abstract: The present disclosure relates to anti-AXL antibodies, immunoconjugates, compositions and method of treatment of cancer with such anti-AXL antibodies, immunoconjugates, or compositions.
-
公开(公告)号:US10155816B2
公开(公告)日:2018-12-18
申请号:US12095023
申请日:2006-11-28
Applicant: Paul Parren , Janine Schuurman , Tom Vink , Willem Karel Bleeker , Jan Van De Winkel , Patrick Van Berkel , Frank Beurskens
Inventor: Paul Parren , Janine Schuurman , Tom Vink , Willem Karel Bleeker , Jan Van De Winkel , Patrick Van Berkel , Frank Beurskens
Abstract: The present invention provides monovalent antibodies with a long half-life when administered in vivo, methods of making such monovalent antibodies, pharmaceutical compositions comprising such antibodies, and uses of the monovalent antibodies.
-
公开(公告)号:US10000570B2
公开(公告)日:2018-06-19
申请号:US14739768
申请日:2015-06-15
Applicant: Genmab A/S
Inventor: Aran Frank Labrijn , Stefan Loverix , Paul Parren , Jan Van De Winkel , Janine Schuurman , Ignace Lasters
Abstract: The present invention relates to positions in the constant region of antibodies, in particular the CH3 region of IgG4, which affect the strength of CH3-CH3 interactions. Mutations that either stabilize or destabilize this interaction are disclosed.
-
公开(公告)号:US09944711B2
公开(公告)日:2018-04-17
申请号:US14990869
申请日:2016-01-08
Applicant: GENMAB A/S
Inventor: Michel De Weers , Tim Walseth , Jan Van De Winkel , Tom Vink , Paul Parren
IPC: C07K16/30 , A61K39/395 , C07K16/28 , A61K45/06 , G01N33/573
CPC classification number: C07K16/2878 , A61K39/3955 , A61K45/06 , C07K16/2896 , C07K2317/21 , C07K2317/33 , C07K2317/34 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/734 , C07K2317/75 , C07K2317/76 , G01N33/573 , G01N2333/91148
Abstract: Isolated monoclonal antibodies which bind to human CD38 and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies.
-
公开(公告)号:US09714297B2
公开(公告)日:2017-07-25
申请号:US14839514
申请日:2015-08-28
Applicant: GENMAB A/S
Inventor: Sandra Verploegen , David P. E. Satijn , Rene M. A. Hoet , Paul Parren , Jan Van De Winkel , Vibeke Miller Breinholt , Eva Ehrnrooth , Ole Baadsgaard , Tom Vink , Willem Karel Bleeker , Mischa Houtkamp , Maroeska Oudshoorn , Rob N. De Jong
IPC: C07K16/36 , A61K39/395 , A61K39/00
CPC classification number: C07K16/36 , A61K39/395 , A61K2039/505 , C07K2317/21 , C07K2317/31 , C07K2317/565 , C07K2317/732 , C07K2317/76 , C07K2317/92
Abstract: Isolated human monoclonal antibodies which bind to human TF and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic and diagnostic methods for using the antibodies.
-
公开(公告)号:US09714294B2
公开(公告)日:2017-07-25
申请号:US13700246
申请日:2011-05-27
Applicant: Bart De Goeij , Edward Norbert Van Den Brink , Simone De Haij , Thilo Riedl , Rene Hoet , Ole Baadsgaard , David Satijn , Jan Van De Winkel , Paul Parren
Inventor: Bart De Goeij , Edward Norbert Van Den Brink , Simone De Haij , Thilo Riedl , Rene Hoet , Ole Baadsgaard , David Satijn , Jan Van De Winkel , Paul Parren
IPC: C07K16/30 , A61K39/395 , C07K16/32 , A61K39/00
CPC classification number: C07K16/30 , A61K2039/505 , C07K16/32 , C07K2317/21 , C07K2317/33 , C07K2317/732 , C07K2317/76 , C07K2317/77 , C07K2317/92 , Y02A50/472
Abstract: Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
-
公开(公告)号:US09657107B2
公开(公告)日:2017-05-23
申请号:US14721709
申请日:2015-05-26
Applicant: GENMAB A/S
Inventor: Joost J. Neijssen , Bart De Goeij , Edward Norbert Van Den Brink , Aran Frank Labrijn , Rene Hoet , Janine Schuurman , Paul Parren , Jan Van De Winkel
IPC: A61K39/395 , C07K16/30 , G01N33/574 , C07K16/28 , A61K45/06 , C07K16/40 , A61K39/00
CPC classification number: C07K16/3076 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K16/2863 , C07K16/40 , C07K2317/21 , C07K2317/31 , C07K2317/35 , C07K2317/524 , C07K2317/526 , C07K2317/53 , C07K2317/565 , C07K2317/71 , C07K2317/74 , C07K2317/76 , C07K2317/92 , G01N33/5748 , G01N2333/912
Abstract: Isolated monoclonal antibodies which bind to human c-Met, the hepatocyte growth factor receptor, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
-
-
-
-
-
-
-
-
-